Kodatef

What is this medication? Kodatef is a prescription medication that contains the active ingredient pretomanid. It belongs to a class of drugs known as nitroimidazoles and is specifically used for the treatment of adults with pulmonary tuberculosis that is either extensively drug-resistant or multidrug-resistant. Because of the complex nature of these infections, this medicine is not used alone but is administered as part of a specific combination regimen alongside bedaquiline and linezolid. The medication works by inhibiting the growth of the bacteria responsible for tuberculosis, known as Mycobacterium tuberculosis. By blocking the synthesis of cell walls and interfering with bacterial metabolism, it helps clear the infection in patients who have not responded to standard treatments or who have highly resistant strains. It is typically prescribed by specialists in infectious diseases and requires strict adherence to the dosing schedule to ensure effectiveness and prevent further antibiotic resistance.